PFRM3 Stock Overview
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical products in Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Profarma Distribuidora de Produtos Farmacêuticos S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$5.35 |
| 52 Week High | R$6.15 |
| 52 Week Low | R$3.04 |
| Beta | 1.3 |
| 1 Month Change | -1.29% |
| 3 Month Change | 13.11% |
| 1 Year Change | 75.41% |
| 3 Year Change | -10.83% |
| 5 Year Change | 28.92% |
| Change since IPO | -79.22% |
Recent News & Updates
Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) 28% Price Boost Is Out Of Tune With Earnings
Mar 01
These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Feb 21Recent updates
Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) 28% Price Boost Is Out Of Tune With Earnings
Mar 01These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Feb 21Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)
Nov 04Investors Will Want Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Growth In ROCE To Persist
Aug 03These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Jun 08These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Sep 26Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Shares Fly 26% But Investors Aren't Buying For Growth
Jan 01Here's Why Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Weighed Down By Its Debt Load
May 28Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Might Have The Makings Of A Multi-Bagger
May 07How Much Of Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Do Institutions Own?
Mar 10Are Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 02
Is Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Using Too Much Debt?
Jan 05What Type Of Shareholders Make Up Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) Share Registry?
Dec 10Shareholder Returns
| PFRM3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -0.2% | -9.3% | -4.5% |
| 1Y | 75.4% | 1.4% | 11.1% |
Return vs Industry: PFRM3 exceeded the BR Healthcare industry which returned 3.4% over the past year.
Return vs Market: PFRM3 exceeded the BR Market which returned 9.9% over the past year.
Price Volatility
| PFRM3 volatility | |
|---|---|
| PFRM3 Average Weekly Movement | 5.9% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 8.6% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: PFRM3 has not had significant price volatility in the past 3 months.
Volatility Over Time: PFRM3's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | n/a | Sammy Birmarcker | www.profarma.com.br |
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical products in Brazil. The company operates through two segments, Distribution and Retail segments. It provides medicines, human drugs, personal hygiene, veterinary, perfumery, and cosmetic and beauty products.
Profarma Distribuidora de Produtos Farmacêuticos S.A. Fundamentals Summary
| PFRM3 fundamental statistics | |
|---|---|
| Market cap | R$652.29m |
| Earnings (TTM) | R$70.40m |
| Revenue (TTM) | R$8.66b |
9.3x
P/E Ratio0.1x
P/S RatioIs PFRM3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PFRM3 income statement (TTM) | |
|---|---|
| Revenue | R$8.66b |
| Cost of Revenue | R$7.37b |
| Gross Profit | R$1.29b |
| Other Expenses | R$1.22b |
| Earnings | R$70.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | 0.57 |
| Gross Margin | 14.92% |
| Net Profit Margin | 0.81% |
| Debt/Equity Ratio | 50.7% |
How did PFRM3 perform over the long term?
See historical performance and comparison